At CytoForge Therapeutics, we are driven by a singular mission, to harness the transformative potential of in-vivo gene editing to redefine the future of medicine. Our multidisciplinary team of scientists, clinicians, and innovators is united by a shared passion for developing next-generation therapies that target the root causes of debilitating and treatment-resistant diseases.
We believe that the convergence of cutting-edge gene editing technologies, artificial intelligence, molecular biology, and precision medicine holds the key to unlocking a new era of curative therapies. From advancing healthcare solutions to pioneering translational research and therapeutic development, we are committed to bridging the gap between discovery and real-world impact.
Every innovation at CytoForge is guided by our unwavering commitment to improving patient outcomes, accelerating the path from bench to bedside, and contributing to a healthier, more hopeful future for humanity. Through our relentless pursuit of scientific excellence, we aim not only to transform lives — but to forge the therapies of the future.
Explore our range of cutting-edge products in development, designed to improve lives and advance science. From diagnostic tools to therapeutic treatments, we are proud to offer some of the most advanced solutions in the industry.

CytoForge Therapeutics was founded in 2025 with a vision of developing novel bio-therapeutic CytoForge Therapeutics was founded in 2025 with a visionary goal — to revolutionize the landscape of modern medicine through the development of novel biotherapeutic products that transform patient care. From its inception, CytoForge has been guided by a deep commitment to innovation, precision, and compassion, aiming to bridge the gap between cutting-edge science and meaningful clinical impact. At CytoForge, science is more than discovery — it’s a promise of hope. Our growing team of researchers, clinicians, and innovators is united by a shared vision: to forge new therapeutic pathways that improve quality of life, extend survival, and ultimately redefine what’s possible in patient care.

At CytoForge Therapeutics, we are advancing next-generation immunotherapies through innovative CAR-based platforms that target both solid tumors and hematological malignancies. Our cutting-edge technologies — including in-vivo CAR-T, CAR-macrophage (CAR-M), and armored suicide switch CARs — are designed to overcome the barriers of the tumor microenvironment while ensuring precision and safety. By enabling direct in-vivo T cell engineering, enhancing immune cell persistence, and integrating smart control mechanisms, we aim to deliver powerful, accessible, and controllable therapies that redefine cancer treatment. Through this pioneering approach, CytoForge is forging a new era of durable, patient-centered immunotherapy.

At CytoForge Therapeutics, our values form the foundation of everything we do — driving our science, guiding our decisions, and shaping our vision for a healthier world. We are driven by innovation, relentlessly pursuing scientific excellence to push the boundaries of what’s possible in gene and cell therapy. We uphold integrity and transparency in our research, partnerships, and patient commitment. Our work is deeply patient-centered, ensuring that every discovery is directed toward improving lives and restoring hope. We believe in the power of collaboration, uniting multidisciplinary teams and global partners to accelerate breakthroughs. Above all, we are guided by compassion, responsibility, and impact — striving not only to advance biotechnology but to create meaningful change for patients, families, and the future of healthcare.
PLOTNO-3893/5805, SHIVAPUR, NEAR SHRUTI VIDYA MANDIR, JAGATPUR, CUTTACK- 754021, ODISHA

Copyright © 2025 Cytoforge Therapeutics Private Limited - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.